Pharmacogenomics: Overview of Applications and Relation to Infusion Therapy

David F Kisor¹, David R Bright, Chelsea R Manion+1

• ¹Manchester University College of Pharmacy, Fort Wayne, Indiana (Drs Kisor and Smith); Ferris State University, Big Rapids, Michigan (Dr Bright); and Cedarville University, Cedarville, Ohio (Dr Manion). David F. Kisor, PharmD, BS, is the chair of pharmaceutical sciences at Manchester University College of Pharmacy. His focus is on the fields of pharmacokinetics-related pharmacogenomics. He has more than 40 publications, including a textbook on pharmacogenetics, and he has served as the chair of the pharmacogenomics special interest group of the American Association of Colleges of Pharmacy. David R. Bright, PharmD, BS, is an associate professor of pharmacy practice at Ferris State University. His focus is on community and ambulatory care pharmacy practice. He has emphasized the incorporation of pharmacogenomics into medication therapy management and collaborative drug therapy management, where he works to evaluate implementation models in the community and in transition-of-care settings. Chelsea R. Manion, PharmD, practices in oncology, inpatient, and infusion-center settings, as well as among underserved populations. Her focus in oncology care is on symptom management, patient education, and interdisciplinary health care collaboration. She is an assistant professor of pharmacy practice at Cedarville University in Cedarville, Ohio. Thomas R. Smith, PharmD, is trained in psychiatry and neurology. He currently focuses his efforts in the inpatient psychiatry setting on therapeutics and patient education. He has included pharmacogenomic data in drug therapy management, focusing on clinical applications. Dr. Smith is an assistant professor of pharmacy practice at Manchester University College of Pharmacy, Fort Wayne, Indiana.